BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 27025204)

  • 1. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
    Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
    J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.
    Augustynowicz-Kopeć E; Siemion-Szcześniak I; Zabost A; Wyrostkiewicz D; Filipczak D; Oniszh K; Gawryluk D; Radzikowska E; Korzybski D; Szturmowicz M
    Pol J Microbiol; 2019; 68(1):15-19. PubMed ID: 31050249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis.
    Fan L; Chen Z; Hao XH; Hu ZY; Xiao HP
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):456-66. PubMed ID: 22487051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.
    Siegel SAR; Cavanaugh M; Ku JH; Kawamura LM; Winthrop KL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
    Saleem N; Saba R; Maddika S; Weinstein M
    Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
    Mazurek GH; Jereb J; Vernon A; LoBue P; Goldberg S; Castro K; ;
    MMWR Recomm Rep; 2010 Jun; 59(RR-5):1-25. PubMed ID: 20577159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
    Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
    Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.
    Yang C; Luo X; Fan L; Sha W; Xiao H; Cui H
    Front Cell Infect Microbiol; 2020; 10():571230. PubMed ID: 33680977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Interferon-γ Release Assays Be Useful for Monitoring the Response to Anti-tuberculosis Treatment?: A Systematic Review and Meta-analysis.
    Pourakbari B; Mamishi S; Benvari S; Sauzullo I; Bedini A; Valentini P; Keicho N; Mahmoudi S
    Arch Immunol Ther Exp (Warsz); 2020 Feb; 68(1):4. PubMed ID: 32016610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Gottschalk R; Nienhaus A
    Chest; 2009 Apr; 135(4):1010-1018. PubMed ID: 19017873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan.
    Takasaki J; Manabe T; Morino E; Muto Y; Hashimoto M; Iikura M; Izumi S; Sugiyama H; Kudo K
    J Infect Chemother; 2018 Mar; 24(3):188-192. PubMed ID: 29108749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).
    Kuznetcova TI; Sauty A; Herbort CP
    Int Ophthalmol; 2012 Oct; 32(5):499-506. PubMed ID: 22661050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.
    Lombardi G; Petrucci R; Corsini I; Bacchi Reggiani ML; Visciotti F; Bernardi F; Landini MP; Cazzato S; Dal Monte P
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.
    Leyten EM; Arend SM; Prins C; Cobelens FG; Ottenhoff TH; van Dissel JT
    Clin Vaccine Immunol; 2007 Jul; 14(7):880-5. PubMed ID: 17507543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.